Stem Cell Therapy Market Report 2023

Stem Cell Therapy Global Market Report 2023 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Other Applications), By EndUser (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Stem Cell Therapy Market

Proud Members Of

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body's natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation. The various sources of the cells include adult stem cells, induced pluripotent stem cells, and embryonic stem cells that are used for the treatment of musculoskeletal disorders, wounds and injuries, cancer, autoimmune disorders, and others. The therapies are used by hospitals and clinics.

The global stem cell therapy market is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Other Applications

4) By End-User: Hospitals, Clinics

The global stem cell therapy market size will grow from $5.14 billion in 2022 to $6.45 billion in 2023 at a compound annual growth rate (CAGR) of 25.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global stem cell therapy market size is expected to grow to $11.88 billion in 2027 at a CAGR of 16.5%.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market growth.

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the stem cell therapy market growth.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in June 2020, Shanghai Cell Therapy Group (SHCell) has recently begun a six-year research collaboration with Professor Qi-Long Ying of the University of Southern California (USC). The Ying laboratory hopes to develop conditions for long-term ex vivo expansion of mouse and human hematopoietic stem and progenitor cells through the project, which is supported by $3.6 million from the Baize Plan Fund.

In July 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Global Stem Cell Technology (GST) for an undisclosed amount. The acquisition completely supports Boehringer Ingelheim's Animal Health strategy, which aims to improve its portfolio capabilities to spur innovation and growth. The purchase comes after a two-year, fruitful relationship that saw the introduction of the first-ever registered stem cell-based veterinary treatment to the European market. GST is a Belgian biotech company that develops and produces state-of-the art stem cell products for horses and pets.

North America was the largest region in the stem cell therapy market in 2022. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the global stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Stem Cell Therapy Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Type

    6.3. Segmentation By Cell Source

    6.4. Segmentation By Application

    6.5. Segmentation By End-User

    7. Stem Cell Therapy Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Type

    7.2.1. Allogeneic Stem Cell Therapy

    7.2.2. Autologous Stem Cell Therapy

    7.3. Segmentation By Cell Source

    7.3.1. Adult Stem Cells

    7.3.2. Induced Pluripotent Stem Cells

    7.3.3. Embryonic Stem Cells

    7.4. Segmentation By Application

    7.4.1. Musculoskeletal Disorders And Wounds & Injuries

    7.4.2. Cancer

    7.4.3. Autoimmune Disorders

    7.4.4. Others

    7.5. Segmentation By End-Users

    7.5.1. Hospitals And Clinics

    7.5.2. Research Centers

    7.5.3. Others

    8. Stem Cell Therapy Trends And Strategies

    8.1. Growing Use of Mesenchymal Stem Cell Therapy

    8.2. Strategic Acquisitions And Partnerships

    8.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells

    8.4. Demand For Stem Cell Therapy Based Treatments

    8.5. Use Of Artificial Intelligence

    9. Impact Of Covid-19 On Stem Cell Therapy Market

    9.1. Introduction

    9.2. Increased Enthusiasm For Stem Cell Therapy

    9.3. Increase In Research And Development Activities

    9.4. Future Outlook

    10. Global Stem Cell Therapy Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

    10.2.1. Drivers Of The Market 2016 – 2021

    10.2.2. Restraints On The Market 2016 – 2021

    10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    10.3.1. Drivers Of The Market 2021 – 2026

    10.3.2. Restraints On The Market 2021 – 2026

    11. Global Stem Cell Therapy Market Segmentation

    11.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.4. Global Stem Cell Therapy Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12. Stem Cell Therapy Market, Regional And Country Analysis

    12.1. Global Stem Cell Therapy Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.2. Global Stem Cell Therapy Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13. Asia-Pacific Stem Cell Therapy Market

    13.1. Asia-Pacific Stem Cell Therapy Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. Background Information

    13.1.4. Government Initiatives

    13.1.5. Regulations

    13.1.6. Regulatory bodies

    13.1.7. Major Associations

    13.1.8. Taxes Levied

    13.1.9. Corporate Tax Structure

    13.1.10. Investments

    13.1.11. Major Companies

    13.2. Asia-Pacific Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.3. Asia-Pacific Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.4. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.5. Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.6. Asia-Pacific Stem Cell Therapy Market: Country Analysis

    13.7. China Stem Cell Therapy Market

    13.8. China Stem Cell Therapy Market Overview

    13.8.1. Country Information

    13.8.2. Market Information

    13.8.3. Background Information

    13.8.4. Government Initiatives

    13.8.5. Regulations

    13.8.6. Regulatory bodies

    13.8.7. Major Associations

    13.8.8. Taxes Levied

    13.8.9. Corporate Tax Structure

    13.8.10. Investments

    13.8.11. Major Companies

    13.9. China Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.10. China Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.11. China Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.12. China Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.13. India Stem Cell Therapy Market

    13.14. India Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.15. India Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.16. India Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.17. India Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.18. Japan Stem Cell Therapy Market

    13.19. Japan Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.20. Japan Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.21. Japan Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.22. Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.23. Australia Stem Cell Therapy Market

    13.24. Australia Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.25. Australia Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.26. Australia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.27. Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.28. Indonesia Stem Cell Therapy Market

    13.29. Indonesia Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.30. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.31. Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.32. South Korea Stem Cell Therapy Market

    13.33. South Korea Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.34. South Korea Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.35. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.36. South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14. Western Europe Stem Cell Therapy Market

    14.1. Western Europe Stem Cell Therapy Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Background Information

    14.1.4. Government Initiatives

    14.1.5. Regulations

    14.1.6. Regulatory Bodies

    14.1.7. Major Associations

    14.1.8. Taxes Levied

    14.1.9. Corporate Tax Structure

    14.1.10. Investments

    14.1.11. Major Companies

    14.2. Western Europe Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.3. Western Europe Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.4. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.5. Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.6. Western Europe Stem Cell Therapy Market: Country Analysis

    14.7. UK Stem Cell Therapy Market

    14.8. UK Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.9. UK Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.10. UK Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.11. UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.12. Germany Stem Cell Therapy Market

    14.13. Germany Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.14. Germany Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.15. Germany Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.16. Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.17. France Stem Cell Therapy Market

    14.18. France Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.19. France Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.20. France Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.21. France Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15. Eastern Europe Stem Cell Therapy Market

    15.1. Eastern Europe Stem Cell Therapy Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Background information

    15.1.4. Government Initiatives

    15.1.5. Regulations

    15.1.6. Regulatory bodies

    15.1.7. Major Associations

    15.1.8. Taxes levied

    15.1.9. Corporate tax structure

    15.1.10. Investments

    15.1.11. Major Companies

    15.2. Eastern Europe Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.3. Eastern Europe Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.4. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.5. Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.6. Eastern Europe Stem Cell Therapy Market: Country Analysis

    15.7. Russia Stem Cell Therapy Market

    15.8. Russia Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.9. Russia Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.10. Russia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.11. Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16. North America Stem Cell Therapy Market

    16.1. North America stem cell therapy Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Background information

    16.1.4. Government Initiatives

    16.1.5. Regulations

    16.1.6. Regulatory bodies

    16.1.7. Major Associations

    16.1.8. Taxes levied

    16.1.9. Corporate tax structure

    16.1.10. Investments

    16.1.11. Major Companies

    16.2. North America Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    16.3. North America Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    16.4. North America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.5. North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.6. North America Stem Cell Therapy Market: Country Analysis

    16.7. USA Stem Cell Therapy Market

    16.8. USA Stem Cell Therapy Market Overview

    16.8.1. Region Information

    16.8.2. Market Information

    16.8.3. Background information

    16.8.4. Government Initiatives

    16.8.5. Regulations

    16.8.6. Regulatory bodies

    16.8.7. Major Associations

    16.8.8. Taxes levied

    16.8.9. Corporate tax structure

    16.8.10. Investments

    16.8.11. Major Companies

    16.9. USA Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    16.10. USA Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    16.11. USA Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.12. USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17. South America Stem Cell Therapy Market

    17.1. South America Stem Cell Therapy Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Background Information

    17.1.4. Government Initiatives

    17.1.5. Regulations

    17.1.6. Regulatory Bodies

    17.1.7. Major Associations

    17.1.8. Taxes Levied

    17.1.9. Corporate Tax Structure

    17.1.10. Investments

    17.1.11. Major Companies

    17.2. South America Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    17.3. South America Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    17.4. South America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.5. South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.6. South America Stem Cell Therapy Market: Country Analysis

    17.7. Brazil Stem Cell Therapy Market

    17.8. Brazil Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    17.9. Brazil Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    17.10. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.11. Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    18. Middle East Stem Cell Therapy Market

    18.1. Middle East Stem Cell Therapy Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Background Information

    18.1.4. Government Initiatives

    18.1.5. Regulations

    18.1.6. Regulatory Bodies

    18.1.7. Major Associations

    18.1.8. Taxes levied

    18.1.9. Corporate tax structure

    18.1.10. Investments

    18.1.11. Major Companies

    18.2. Middle East Stem Cell Therapy Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    18.3. Middle East Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    18.4. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    18.5. Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    19. Africa Stem Cell Therapy Market

    19.1. Africa Stem Cell Therapy Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Background Information

    19.1.4. Government Initiatives

    19.1.5. Regulations

    19.1.6. Regulatory Bodies

    19.1.7. Major Associations

    19.1.8. Taxes Levied

    19.1.9. Corporate Tax Structure

    19.1.10. Investments

    19.1.11. Major Companies

    19.2. Africa Stem Cell Therapy Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    19.3. Africa Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    19.4. Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    20. Stem Cell Therapy Global Market Competitive Landscape

    20.1. Company Profiles

    20.2. Smith & Nephew plc

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Fujifilm Holding Corporation

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Thermo Fisher Scientific Inc.

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Takara Bio Inc.

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. MEDIPOST Co., Ltd.

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Stem Cell Therapy Market Pipeline Analysis

    22. Key Mergers And Acquisitions In The Stem Cell Therapy Market

    22.1. Catalent Acquired RheinCell Therapeutics

    22.2. Sanofi Acquired Kiadis

    22.3. Vertex Pharmaceuticals Acquired Semma Therapeutics

    22.4. Bayer Acquired BlueRock Therapeutics

    22.5. Evotech Acquired NCARDIA

    23. Stem Cell Therapy Market Opportunities And Strategies

    23.1. Global Stem Cell Therapy Market In 2026 – Countries Offering Most New Opportunities

    23.2. Global Stem Cell Therapy Market In 2026 – Segments Offering Most New Opportunities

    23.3. Global Stem Cell Therapy Market In 2026 – Growth Strategies

    23.3.1. Market Trend Based Strategies

    23.3.2. Competitor Strategies

    24. Stem Cell Therapy Market, Conclusions And Recommendations

    24.1. Conclusions

    24.2. Recommendations

    24.2.1. Product

    24.2.2. Place

    24.2.3. Price

    24.2.4. Promotion

    24.2.5. People

    25. Appendix

    25.1. Market Data Sources

    25.2. Research Methodology

    25.3. Currencies

    25.4. Research Inquiries

    25.5. The Business Research Company

    26. Copyright and Disclaimer

List Of Tables

    Table 1: Global Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 2: Global Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3: Global Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4: Global Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5: Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6: Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7: Global Stem Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8: Global Stem Cell Therapy Market, Segmentation By Types, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9: Global Stem Cell Therapy Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10: Global Stem Cell Therapy Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11: Global Stem Cell Therapy Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12: Global Stem Cell Therapy Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13: Global Stem Cell Therapy Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 14: Global Stem Cell Therapy Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 15: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 16: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 17: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 18:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 19: Asia-Pacific Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 20: Asia-Pacific Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 21: Asia-Pacific Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 22: Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 23: Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 24: Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 25: Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 26: China GDP Per Capita, 2015-2020, $
  • Table 27: China, Population By Age Group, 2015-2025, Thousands
  • Table 28:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 29: China Stem Cell Therapy Market, Biologics Market Size, 2016-2026, $ Billion
  • Table 30: China Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 31: China Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 32: China Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 33: China Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 34: China Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35: China Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36: India Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 37: India Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 38: India Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39: India Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40: India Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 41: India Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 42: Japan Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 43: Japan Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 44: Japan Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45: Japan Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46: Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47: Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48: Australia Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 49: Australia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 50: Australia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51: Australia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52: Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 53: Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 54: Indonesia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 55: Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 56: Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 57: Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 58: Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 59: South Korea Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 60: South Korea Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 61: South Korea Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 62: South Korea Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 63: South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 64: South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 65: Western Europe GDP Per Capita, 2015-2020, $
  • Table 66: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 67:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 68:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 69: Western Europe Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 70: Western Europe Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 71: Western Europe Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 72: Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 73: Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 74: Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 75: Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 76: UK Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 77: UK Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 78: UK Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 79: UK Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 80: UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 81: UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 82: Germany Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 83: Germany Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 84: Germany Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 85: Germany Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 86: Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87: Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88: France Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 89: France Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 90: France Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 91: France Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 92: France Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 93: France Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 94: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 95: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 96:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 97:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 98: Eastern Europe Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 99: Eastern Europe Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 100: Eastern Europe Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 101: Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 102: Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 103: Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 104: Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 105: Russia Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 106: Russia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 107: Russia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 108: Russia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 109: Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 110: Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 111: North America GDP Per Capita, 2015-2020, $
  • Table 112: North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 113:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 114:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 115: North America Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 116: North America Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 117: North America Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 118: North America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 119: North America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 120: North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 121: North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 122: USA GDP Per Capita, 2015-2020, $
  • Table 123: USA, Population By Age Group, 2015-2025, Thousands
  • Table 124:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 125: USA Stem Cell Therapy Market, Biologics Market Size, 2016-2026, $ Billion
  • Table 126: USA Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 127: USA Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 128: USA Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 129: USA Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 130: USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 131: USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 132: South America GDP Per Capita, 2015-2020, $
  • Table 133: South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 134:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 135:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 136: South America Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 137: South America Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 138: South America Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 139: South America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 140: South America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 141: South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 142: South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 143: Brazil Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 144: Brazil Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 145: Brazil Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 146: Brazil Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 147: Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 148: Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 149: Middle East GDP Per Capita, 2015-2020, $
  • Table 150: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 151:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 152:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 153: Middle East Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 154: Middle East Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Table 155: Middle East Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 156: Middle East Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 157: Middle East Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 158: Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 159: Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 160: Africa GDP Per Capita, 2015-2020, $
  • Table 161: Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 162:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 163:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 164: Africa Stem Cell Therapy Market, Biologics Market Size, By Country, 2016-2026, $ Billion
  • Table 165: Africa Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 166: Africa Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 167: Africa Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 168: Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 169: Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 170: Global Stem Cell Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 171: Smith & Nephew plc – Financial Overview, 2016 - 2020, $ Billion
  • Table 172: Fujifilm Holding Corporation – Financial Overview, 2016 - 2020, $ Billion
  • Table 173: Thermo Fisher Scientific, Inc – Financial Overview, 2016 - 2020, $ Billion
  • Table 174: Takara Bio Inc. – Financial Overview, 2016 - 2020, $ Billion
  • Table 175: MEDIPOST Co., Ltd. – Financial Overview, 2016 - 2020, $ Billion
  • Table 176: Global Stem Cell Therapy Market, Pipeline Analysis
  • Table 177: Global Stem Cell Therapy Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 178: Global Stem Cell Therapy Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
  • Table 179: Global Stem Cell Therapy Market Size Gain ($ Million), Segmentation By Cell Source, 2021 – 2026
  • Table 180: Global Stem Cell Therapy Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
  • Table 181: Global Stem Cell Therapy Market Size Gain ($ Million), Segmentation By End User, 2021 – 2026
  • Table 182: Stem Cell Therapy Market Data Sources

List Of Figures

    Figure 1: Global Stem Cell Therapy Market Segmentation By Type
  • Figure 2: Global Stem Cell Therapy Market Segmentation By Cell Source
  • Figure 3: Global Stem Cell Therapy Market Segmentation By Application
  • Figure 4: Global Stem Cell Therapy Market Segmentation By End-User
  • Figure 5: Global Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 6: Global Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 7: Global Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8: Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9: Global Stem Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10: Global Stem Cell Therapy Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11: Global Stem Cell Therapy Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 12: Global Stem Cell Therapy Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 13: Asia-Pacific Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 14: Asia-Pacific Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 15: Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 16: Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 17: China Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 18: China Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 19: China Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 20: China Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 21: India Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 22: India Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 23: India Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 24: India Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 25: Japan Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 26: Japan Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 27: Japan Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 28: Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 29: Australia Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 30: Australia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 31: Australia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 32: Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 33: Indonesia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 34: Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35: Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 36: South Korea Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 37: South Korea Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 38: South Korea Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 39: South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 40: Western Europe Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 41: Western Europe Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 42: Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 43: Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 44: UK Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 45: UK Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 46: UK Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47: UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 48: Germany Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 49: Germany Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 50: Germany Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51: Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 52: France Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 53: France Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 54: France Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55: France Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 56: Eastern Europe Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 57: Eastern Europe Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 58: Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59: Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 60: Russia Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 61: Russia Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 62: Russia Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 63: Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 64: North America Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 65: North America Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 66: North America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 67: North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 68: USA Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 69: USA Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 70: USA Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71: USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 72: South America Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 73: South America Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 74: South America Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75: South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 76: Brazil Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 77: Brazil Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 78: Brazil Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 79: Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 80: Middle East Stem Cell Therapy Market, Historic, 2016 – 2021, $ Million
  • Figure 81: Middle East Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 82: Middle East Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 83: Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 84: Africa Stem Cell Therapy Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 85: Africa Stem Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86: Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 87: Global Stem Cell Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 88: Smith & Nephew plc – Financial Overview, 2016 – 2020, $ Billion
  • Figure 89: Fujifilm Holding Corporation – Financial Overview, 2016 – 2020, $ Billion
  • Figure 90: Thermo Fisher Scientific, Inc – Financial Overview, 2016 – 2020, $ Billion
  • Figure 91: Takara Bio Inc. – Financial Overview, 2016 – 2020, $ Billion
  • Figure 92: MEDIPOST Co., Ltd. – Financial Overview, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report